Type I interferons in host defence and inflammatory diseases

Mary K. Crow(Cornell University), Lars Rönnblom(Uppsala University)
Lupus Science & Medicine
May 1, 2019
10.1136/lupus-2019-000336
Cited by 120

Related Papers

Interferon pathway in SLE: one key to unlocking the mystery of the disease
|Lupus Science & Medicine|2019|338
Systemic lupus erythematosus and the type I interferon system
|Arthritis Research|2003|160
Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR‐215757), a new quinoline‐3‐carboxamide derivative: Studies in lupus‐prone mice and a multicenter, randomized, double‐blind, placebo‐controlled, repeat‐dose, dose‐ranging study in patients with systemic lupus erythematosus
|Arthritis & Rheumatism|2011|124
Systemic Lupus Erythematosus Immune Complexes Increase the Expression of SLAM Family Members CD319 (CRACC) and CD229 (LY-9) on Plasmacytoid Dendritic Cells and CD319 on CD56dim NK Cells
|The Journal of Immunology|2013|37